 |
| Global Genital Warts Treatment Market Size |
Genital warts treatment products are topical medications used
for the removal of genital warts caused by human papillomavirus (HPV)
infection. These treatments help reduce warts and associated itching, burning
sensation.
The global
genital warts treatment market is estimated to be valued at US$ 1785.61 Mn in 2023 and is expected
to exhibit a CAGR of 6.3% over the
forecast period 2023-2030, as highlighted in a new report published by Coherent
Market Insights.
Market key trends:
The increasing prevalence of genital warts globally is the primary factor
driving the growth of the genital warts treatment market. As per the Centers
for Disease Control and Prevention (CDC), approximately 40% of sexually active
men and women get genital HPV infection at some point in their lives.
Furthermore, according to the World Health Organization (WHO), each year nearly
354 million people worldwide get infected with HPV. Thus, the rising cases of
genital HPV infection and genital warts are expected to propel the demand for
genital warts treatments over the forecast period.
Segment Analysis
The global genital warts treatment market is dominated by topical treatments
which account for over 70% of the market share. Creams and gels are the most
widely used topical treatments for genital warts as they are convenient to
apply, have fewer side effects compared to other modalities, and can be
administered by patients themselves at home.
Key Takeaways
The Global
Genital Warts Treatment Market Size is expected to witness high growth
over the forecast period of 2023 to 2030. The market is projected to grow at a CAGR of 6.3% during this period and
reach a size of US$ 1785.61 Mn by
2023.
Regional analysis
North America currently accounts for the largest share of the global genital
warts treatment market due to high awareness levels about STDs and their
treatment options in the region. However, the Asia Pacific region is expected
to witness the fastest growth over the forecast period supported by factors
such as the rising incidence of HPV infections, growing medical tourism
industry and improvements in healthcare infrastructure in developing countries.
Key players
Key players operating in the genital warts treatment market are DJO Global,
Inc., BSN medical (now part of Essity), Smith & Nephew plc, medi GmbH &
Co. KG, SIGVARIS Group, Bio Compression Systems, Inc., Tactile Medical, RIKEN
SEIKI CO., LTD., Paul Hartmann AG, 3M Company, Gottfried Medical, Inc., Mego
Afek AC Ltd., Abov Semiconductor, Persys Medical, BTL Industries, Human Meditek
Co., Ltd., Huntleigh Healthcare Limited (part of Arjo), KCI Licensing, Inc., Beijing
Huibo Medical Device Co., Ltd., Bioinicia S.L.
Get More Insights On This Topic: https://www.ukwebwire.com/genital-warts-treatment-market-scope/